m+Medelevator.RU
← Поиск публикаций
JACC. Advances · 2025

Sex Differences in the Clinical Recognition of Significant Aortic Stenosis.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Crousillat Daniela, Shariff Dayana, Duan Rong, Tanguturi Varsha, Elmariah Sammy

Аннотация

BACKGROUND: Women with significant aortic stenosis (AS) are under-represented among patients undergoing aortic valve replacement in the United States as compared with men despite similar disease prevalence.

OBJECTIVES: This study evaluated the impact of sex on the clinical recognition of significant AS following diagnostic transthoracic echocardiogram (TTE).

METHODS: Using data from a large administrative multicenter database, we assessed rates of clinical diagnosis of AS defined by assignment of an Internal Classification Diagnosis (ICD) code for AS following a diagnostic TTE. Fine-Gray models were used to evaluate the 1-year cumulative rate of AS diagnosis by sex, AS severity, and AS phenotype accounting for competing risk of death.

RESULTS: Among 2,036 included patients (48.9% female, 51.1% male), the 1-year rate of clinical recognition following a diagnostic TTE with at least moderate AS was low (52.4%), and women were less likely as compared with men to receive a clinical diagnosis of AS (55.7% male vs 48.9% female; P = 0.003). Specifically, among patients with severe AS, women were less likely to receive an ICD diagnosis as compared with males (64.1% vs 74.3%), driven primarily by lower rates of clinical recognition of severe low gradient AS (66.9% male vs 54.3% female; P = 0.004).

CONCLUSIONS: Rates of clinical recognition of AS following a diagnostic TTE are low, and vary significantly by sex, AS disease severity, and severe AS phenotype. Further studies are needed to maximize the clinical recognition of TTE-confirmed AS and to mitigate sex disparities in diagnosis and treatment.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты